Does DUPILUMAB Cause Inappropriate schedule of product administration? 14,927 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14,927 reports of Inappropriate schedule of product administration have been filed in association with DUPILUMAB (Dupixent). This represents 3.9% of all adverse event reports for DUPILUMAB.
14,927
Reports of Inappropriate schedule of product administration with DUPILUMAB
3.9%
of all DUPILUMAB reports
30
Deaths
509
Hospitalizations
How Dangerous Is Inappropriate schedule of product administration From DUPILUMAB?
Of the 14,927 reports, 30 (0.2%) resulted in death, 509 (3.4%) required hospitalization, and 2 (0.0%) were considered life-threatening.
Is Inappropriate schedule of product administration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 14,927 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Inappropriate schedule of product administration?
ADAPALENE (16,473)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546)
INSULIN GLARGINE (8,982)
INFLIXIMAB (6,847)
INFLIXIMAB-DYYB (5,977)
SECUKINUMAB (4,817)
DULAGLUTIDE (3,606)
VEDOLIZUMAB (3,259)
SACUBITRIL\VALSARTAN (2,870)
ACETAMINOPHEN (2,248)
Which DUPILUMAB Alternatives Have Lower Inappropriate schedule of product administration Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE